Evaluation of c-Abl inhibitor vodobatinib in subjects with early Parkinson's disease: a phase 2, randomized, double-blind, placebo-controlled study
评估 c-Abl 抑制剂 vodobatinib 在早期帕金森病患者中的疗效:一项 2 期随机、双盲、安慰剂对照研究
期刊:Npj Parkinsons Disease
影响因子:8.2
doi:10.1038/s41531-026-01275-1
Sarva, Harini; Pahwa, Rajesh; Hernandez-Vara, Jorge; Goldstein, Mark A; Borgohain, Rupam; Factor, Stewart A; Inamdar, Sandeep; Love, Damon; Hames, Carrie; Fu, Yiyong; Mergel, Victor; Goldfine, Andrew; Kumar, Chandra; Piccoli, Steven P; Yao, Siu-Long; Hurko, Orest